Impax Asset Management Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Buy |
|
|||||
|
2025
Q1 | $11.1M | Sell |
|
|||||
|
2024
Q4 | $35.7M | Buy |
|
|||||
|
2024
Q3 | $9.79M | Buy |
|
|||||
|
2024
Q2 | $6.88M | Hold |
|
|||||
|
2024
Q1 | $6.9M | Sell |
|
|||||
|
2023
Q4 | $14.5M | Sell |
|
|||||
|
2023
Q3 | $15.2M | Sell |
|
|||||
|
2023
Q2 | $18.9M | Hold |
|
|||||
|
2023
Q1 | $20.2M | Buy |
|
|||||
|
2022
Q4 | $20.9M | Buy |
|
|||||
|
2022
Q3 | $15.9M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $6.49M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.98M | Buy |
|